BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 19346369)

  • 21. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
    Osman ME; Mockenhaupt FP; Bienzle U; Elbashir MI; Giha HA
    Infect Genet Evol; 2007 Jan; 7(1):52-9. PubMed ID: 16690361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Purworejo district, Central Java Province, Indonesia.
    Syafruddin D; Asih PB; Aggarwal SL; Shankar AH
    Am J Trop Med Hyg; 2003 Dec; 69(6):614-20. PubMed ID: 14740877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola.
    Foumane Ngane V; Allico Djaman J; Culeux C; Piette N; Carnevale P; Besnard P; Fortes F; Basco LK; Tahar R
    Malar J; 2015 Mar; 14():113. PubMed ID: 25889865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
    Tahar R; Basco LK
    Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR.
    Toma H; Imada Y; Vannachone B; Miyagi M; Kobayashi J; Uechi G; Pethuvang R; Manivong K; Phompida S; Sato Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):602-4. PubMed ID: 16124424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Widespread occurrence of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene haplotype SVMNT in P. falciparum malaria in India.
    Vathsala PG; Pramanik A; Dhanasekaran S; Devi CU; Pillai CR; Subbarao SK; Ghosh SK; Tiwari SN; Sathyanarayan TS; Deshpande PR; Mishra GC; Ranjit MR; Dash AP; Rangarajan PN; Padmanaban G
    Am J Trop Med Hyg; 2004 Mar; 70(3):256-9. PubMed ID: 15031513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.
    Menard D; Djalle D; Yapou F; Manirakiza A; Talarmin A
    Am J Trop Med Hyg; 2006 Feb; 74(2):205-10. PubMed ID: 16474071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
    Méndez F; Herrera S; Murrain B; Gutiérrez A; Moreno LA; Manzano M; Muñoz A; Plowe CV
    Am J Trop Med Hyg; 2007 Sep; 77(3):438-43. PubMed ID: 17827356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France in 2004 2006.
    Parola P; Pradines B; Simon F; Carlotti MP; Minodier P; Ranjeva MP; Badiaga S; Bertaux L; Delmont J; Morillon M; Silai R; Brouqui P; Parzy D
    Am J Trop Med Hyg; 2007 Sep; 77(3):431-7. PubMed ID: 17827355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in Nigeria.
    Adegbola AJ; Ijarotimi OA; Ubom AE; Adesoji BA; Babalola OE; Hocke EF; Hansson H; Mousa A; Bolaji OO; Alifrangis M; Roper C
    Malar J; 2023 Mar; 22(1):71. PubMed ID: 36859238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
    Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH
    Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmodium falciparum: higher incidence of molecular resistance markers for sulphadoxine than for pyrimethamine in Kasangati, Uganda.
    Sendagire H; Kyabayinze D; Swedberg G; Kironde F
    Trop Med Int Health; 2005 Jun; 10(6):537-43. PubMed ID: 15941416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.
    Schousboe ML; Rajakaruna RS; Salanti A; Hapuarachchi HC; Galappaththy GN; Bygbjerg IC; Amerasinghe PH; Konradsen F; Alifrangis M
    Malar J; 2007 Mar; 6():28. PubMed ID: 17349045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiology and evolution of drug-resistant genes in the malaria parasite Plasmodium falciparum in southwestern Nigeria.
    Oboh MA; Singh US; Antony HA; Ndiaye D; Badiane AS; Ali NA; Bharti PK; Das A
    Infect Genet Evol; 2018 Dec; 66():222-228. PubMed ID: 30316883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short report: molecular markers associated with Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in the Democratic Republic of Congo.
    Cohuet S; Bonnet M; Van Herp M; Van Overmeir C; D'Alessandro U; Guthmann JP
    Am J Trop Med Hyg; 2006 Jul; 75(1):152-4. PubMed ID: 16837723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana.
    Mockenhaupt FP; Bedu-Addo G; Eggelte TA; Hommerich L; Holmberg V; von Oertzen C; Bienzle U
    J Infect Dis; 2008 Nov; 198(10):1545-9. PubMed ID: 18834303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
    A-Elbasit IE; Alifrangis M; Khalil IF; Bygbjerg IC; Masuadi EM; Elbashir MI; Giha HA
    Malar J; 2007 Aug; 6():108. PubMed ID: 17686173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impacts of Antimalarial Drugs on
    Hemming-Schroeder E; Umukoro E; Lo E; Fung B; Tomás-Domingo P; Zhou G; Zhong D; Dixit A; Atieli H; Githeko A; Vardo-Zalik A; Yan G
    Am J Trop Med Hyg; 2018 Mar; 98(3):692-699. PubMed ID: 29363453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular determination of antifolate resistance associated point mutations in Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthetase (dhps) genes among the field samples in Arunachal Pradesh.
    Sharma J; Khan SA; Dutta P; Mahanta J
    J Vector Borne Dis; 2015 Jun; 52(2):116-21. PubMed ID: 26119542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular surveillance for drug-resistant Plasmodiumfalciparum malaria in Malawi.
    Nkhoma S; Molyneux M; Ward S
    Acta Trop; 2007 May; 102(2):138-42. PubMed ID: 17544355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.